Answers are grounded in this paper and cite their sources.
When added to adrenocortical mitochondria, metyrapone, amphenone and aminoglutethimide induce type II difference spectra, and block both the initial rate of malate-linked cytochrome P-450 reduction and also the DOC-induced increase in this rate. Removing the -NH 2 group from aminoglutethimide shifts the spectrum to shorter wavelengths and reduces its effectiveness in blocking P-450 reduction. These compounds appear to block steroid hydroxylation by binding to oxidized P-450 and only very slowly allowing the P-450 to be reduced.
No takes yet. Share an insight, caveat, or question.
McIntosh et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: